Intracranial Pressure (ICP) Monitoring Market Research Report - Forecast to 2027

Intracranial Pressure (ICP) Monitoring Market Research Report: Information by Route of Intervention (Intraventricular and Epidural Sensor), Technique (Invasive and Non-Invasive), Application (Traumatic Brain Injury and Subarachnoid Hemorrhage), Device (Intraventricular Catheter and Epidural Sensors), End-User (Hospitals and Clinics, Trauma Centers and others) -Forecast Till 2027

ID: MRFR/MED/0232-CR | February 2021 | Region: Global | 129 pages

Intracranial Pressure (ICP) Monitoring Market Overview


With a projected CAGR of 7.1% during the forecast period, the intracranial pressure (ICP) monitoring market expects to touch a market value of USD 2,013.9 million by the end of 2024. The intracranial pressure monitoring device available in the market used to monitor the intracranial pressure works on measuring the pressure inside the skull after a trauma or accident.


Neurovascular diseases have long-lasting effects on the spinal cord and the cerebrovascular system. These diseases include arteriovenous malformation, aneurysms, dural arteriovenous fistula, and cerebral hemorrhage. All these conditions can be treated in an effective way with the help of intracranial pressure monitoring anesthesia. The use of these devices has been increasing across the world because of their efficiency and increased trauma and injury cases. The market is expecting a quick and steady increase in the coming years.


COVID-19 Analysis


The pandemic has bought some severe complications in the lives of almost everyone across the globe. The businesses have been affected to a great extent as well. While none of us knows what the future holds for us and when we would get rid of this, we can at least change the way we have been living and working to ensure we walk with the flow. The intracranial pressure (ICP) monitoring market reports that have been prepared after thorough study and research by the industry experts provide a platform to the business owners to combat the losses that the business has incurred during the period and ensure that the future can be better. The reports have all the guidelines that the company can follow for efficient working.


Descriptions and guidance are all provided in a detailed manner. It has been ensured that COVID-19 does not impart any more ill effects to all the businesses within the pressure monitoring devices market.


Intracranial Pressure (ICP) Monitoring Market Dynamics


Drivers -The factors driving the growth of the brain pressure symptoms monitoring devices market mainly consist of the increase in the cases of neurovascular diseases. Such diseases include conditions like brain aneurysms and the malformations of arteries and veins.


Growth -An increase in the expenditures that people have been making across the world has also led to a boost in the demand for treatments for various chronic illnesses. The developing countries in the Asia Pacific region have been experiencing an increased population of patients with neurovascular problems and also the growth in the healthcare sector. All these factors have been responsible for increasing the demand for intracranial pressure monitoring devices and subsequently changing the market.


Restraints -Certain factors have been acting as a restraint in the growth of the intracranial pressure (ICP) monitoring market. These include the high costs of implantable wireless intracranial pressure monitoring devices. These have been hampering the development of the market in the forecast period.


Regulatory implications


The pressure monitoring devices market is not directly affected by any of the rules and regulations laid down by the regulatory bodies and governments in various regions across the globe. The fact that the devices are used directly in the living beings needs to have a surety if working at an efficient pace and the working should be perfect. There are, however, some regulations that include the certification of the devices, which are anyways necessary by various regulatory bodies to ensure the compatibility they bring along for efficient working. With the increased use of the devices in treating chronic diseases, its demand and supply have increased many folds and are likely to take a steep turn towards success.


Global Intracranial Pressure (ICP) Monitoring Market Size, by Route of Intervention, 2017 (USD Million)  Intracranial Pressure (ICP) Monitoring Market


Source: MRFR Analysis


Segmentation overview


The intracranial pressure (ICP) monitoring market can be classified into various segments:



  • Based on the route of intervention

  • Based on the technique

  • based on the application

  • Based on the device

  • Based on the end-user.


Based on the route of intervention: Based on the way of application, the intracranial pressure (ICP) monitoring market can be subdivided into the following:



  • Epidural sensors

  • Intraventricular

  • Others


The standard procedure involves the intraventricular route. The epidural does not provide accurate results.


Based on the technique: Based on the technique, the intracranial pressure (ICP) monitoring market has the following subcategories:



  • Invasive

  • Non-invasive intracranial pressure monitoring device market


The invasive segment can be further divided into tympanic membrane displacement, transcranial doppler ultrasonography, MRI/CR, and optic nerve sheath diameter sonography. All these techniques require high-level expertise to carry out the procedures.


Based on the application: Based on the application, the intracranial pressure (ICP) monitoring market can be subdivided into:



  • Intracerebral hemorrhage

  • Traumatic brain injury

  • Meningitis

  • Subarachnoid hemorrhage

  • Others


The traumatic brain injury segment dominates the market.


Based on the device: Based on the device, the intracranial pressure (ICP) monitoring market can be subdivided into the following:



  • Subarachnoid screws

  • Epidural sensors

  • Fiber optic monitors

  • Non-invasive intracranial pressure monitoring device market ICP monitors

  • Infra ventricular catheters


The intraventricular catheter segment dominates the market


Based on the end-user: Based on the end-user, the intracranial pressure (ICP) monitoring market has the following subtypes:



  • Trauma centers

  • Hospitals and clinics


The hospital and clinics segment dominate the market.


Global Intracranial Pressure (ICP) Monitoring Market Share, by Region, 2017 (%)  Intracranial Pressure (ICP) Monitoring Market


Source: MRFR Analysis


Regional analysis


Based on the regions, the intracranial pressure (ICP) monitoring market can be divided into Europe, the Americas, the Asia Pacific and the Middle East, and Africa.


Americas dominate the market with the largest share it has an expected market value of USD 844.8 million. The central region for its dominance is the advancements in technologies and the improved healthcare systems.


Europe holds the second rank in market dominance. High blood pressure has an increased chance of bleeding, and such cases have been growing in Europe. This has been providing favorable conditions for the growth of the market.


Asia Pacific region is expecting a CAGR of 7.4% during the forecast period. In the countries like India, China, and Japan, the growth is expected to be quick.


The Middle East and Africa is expected to experience slow growth


Competitive Landscape


The major intracranial pressure monitoring device manufacturers include Integra LifeSciences Corporation (US), Natus Medical Incorporated (US), DePuy Synthes (US), Terumo Corporation (US), Spiegelberg GmbH & Co. KG (Germany), Medtronic Plc (Ireland), RAUMEDIC Inc. (Germany), Boston Neurosciences (US) and Sophysa SA (France)


All these intracranial pressure monitoring device manufacturers have been working collectively in the growth of the brain pressure symptoms monitoring devices market. Various acquisitions, collaborations, and mergers amongst these companies have bought about a wave of change in the market. Also, they have been working on the planned strategies and plans and implementing them efficiently for the market's good.


Recent Advancements


Here is the list of recent advancements in the market:



  • Terumo Corporation purchased Sequent Medical Inc in July 2016. After the purchase, the company has been focusing on expanding the horizons in neurovascular products.

  • The neurosurgery assets of Integra life sciences were acquired by Natus medical incorporated in September 2017. It entered into the neurosurgery segment after this acquisition

  • I A study on Harmony transcatheter pulmonary valve was announced by Medtronic plc after a wretch of two years. It was presented in the 41st annual scientific session society.

  • Various steps are being taken towards the technological advancements within the market.

  • Steps to reduce the cost of the procedure are being implemented to ensure it gets available to a more extensive section of the population worldwide and helps treat more people.


Report overview


The report prepared for the companies dealing in the implantable wireless intracranial pressure (ICP) monitoring market has everything they need to smooth the business. They provide a Market overview and the COVID-19 analysis of the market and its impact on the industry worldwide. It also has the Market dynamics reports, which contain the factors responsible for the growth and the factors that have been hampering the development of the market. The regulatory implications have also been discussed in detail. The segmentation of the market based on administration, technique, end-user, and method has been discussed in detail in the intracranial pressure (ICP) monitoring market report.


Also, the regional analysis has been provided. The news of the major players in the market has been given in the report to let the business self analyze their business position in the market. The recent advancement, including the technological advances, has also been included in the report.



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2024: USD 2,013.9 Million
  • 2027: Significant Value
  •   CAGR   7.1% (2018-2024)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units    Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Route of Intervention, Technique, Application, Device, End User
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Integra LifeSciences Corporation (US), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), RAUMEDIC Inc. (Germany), Sophysa SA (France), Boston Neurosciences (US), Medtronic Plc (Ireland), Terumo Corporation (US) and Natus Medical Incorporated (US).
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers

  • Rising incidences of neurological disorders, autoimmune and cardiovascular diseases, brain disorders, and sleep disorders
  • Rising awareness regarding neurodegenerative diseases
  • Technological advancements in brain monitoring devices


  • Frequently Asked Questions (FAQ) :


    The intraventricular catheter segment would continue its dominance until 2027.

    The hospitals & clinics segment would lead the market in the coming years.

    The Americas would dominate the global Intracranial Pressure (ICP) Monitoring Market.

    Intracranial Pressure Monitoring Market – Summary


    Overview:


    Time is of the essence when it comes to traumatic brain injuries. Constant monitoring of the intracranial pressure (ICP) is needed to avoid anything fatal. The idea is to measure cerebrospinal fluid (CSF) pressure with a small pressure-sensitive probe directly inserted through the skull. Constant monitoring, especially during sleep, is necessary to determine abnormalities and its connection with symptoms. The global intracranial pressure monitoring market can expect a substantial 7.1 % CAGR during the forecast period (2018-2024), asserts Market Research Future (MRFR). In their holistic take on the intracranial pressure monitoring market, MRFR included several factors that can substantially influence the market before dissecting various segments in detail for better predictive analysis.


    Neurovascular diseases such as a brain aneurysm, and arteriovenous malformations (AVM) are getting much prominence. A blend of both, occurrence and awareness, regarding such diseases, is working in favor of the intracranial pressure monitoring market. Furthermore, healthcare expenditures in developed countries are on the rise giving therapeutics proper foothold. Meanwhile, developing countries, with revamped healthcare sector and increased health-related awareness, are opening up as an untapped market with massive opportunities for the intracranial pressure monitoring market expansion.


    Reimbursing policies of governments are playing a crucial role in providing patients with holistic care. Worrying over payment, in most cases, is no longer an option. At the same time, reimbursements give patients the opportunity to cure their diseases from the root. In the U.S. alone, a 2015 report of the American Hospital Association reveals, 88% of the Medicare patients and 90% of the Medicaid patients have been reimbursed. Patients can always take it as a head start. At the same time, the rising number of traumatic brain injuries are raising quite a few eyebrows. Reports published by the Centers for Disease Control and Prevention (CDC) in 2017, North America has suffered more than 1.75 million traumatic brain injuries. Only timely interventions from skilled physicians can deliver a favorable result. Advances in technology have empowered doctors, and a perfect example would be ICP monitoring. Revamped healthcare sectors across the globe have realized its importance and are incorporating the system into their infrastructure.


    But the market is not without its fair share of uphill tasks. Devices associated with intracranial pressure monitoring incur a high procedural cost which many prefer to avoid. At the same time, the market is hit by a severe shortage of skilled professionals which could brew troubles for the normal market growth during the forecast period.   


    Industry Opportunity:


    Endovascular embolization is a treatment perfect for brain aneurysms where natural access through the bloodstream is necessary. However, it requires monitoring of the intracranial function at every step. A rise in such procedure can trigger growth in the intracranial pressure monitoring market as well.


    After the hiccups, experienced between 2014-2016, the global GDP is recovering which means healthcare sector is also going to experience substantial growth. This is already visible in various sub-segments of the healthcare industry and intracranial pressure monitoring I no exception.


    Segmentation:


    By route of intervention, the ICP monitoring can be segmented into intraventricular, epidural sensor, and others. Among these, intraventricular is expecting the largest leap by 7.4% CAGR during the forecast period from USD 774.5 million in 2018 to USD 1,190 million by 2024. The next in line would be an epidural sensor with a market projection of USD 678.5 million valuation.


    By technique, the ICP monitoring market can be segmented into invasive and non-invasive. Invasive segment can enjoy a robust growth by 7.1% CAGR during the review period and reach USD 1,979 million by 2024 from USD 1,310.7 million valuation of 2018.


    Based on application, the ICP monitoring market includes traumatic brain injury, intracerebral hemorrhage, subarachnoid hemorrhage, meningitis, and others. With a 7.5% CAGR during the review period, the highest among the sub-segments, traumatic brain injury is expected to lead the market from the front. Its valuation would go up to USD 1,141.8 million by 2024 from USD 741.1 million of 2018 during the forecast period.


    Device-wise, the ICP monitoring market comprises intraventricular catheter, subarachnoid screw, non-invasive ICP monitor, epidural sensors, and others. Intraventricular catheter’s growth will be substantial, and it would reach USD 922.7 million by 2024 from USD 600.6 million with a 7.4% CAGR during the assessment period.


    Based on end-users, the ICP monitoring market can be segmented into hospitals & clinics, trauma centers, and others. With an expected market valuation of USD 1,299.5 million by 2024 and an astonishing CAGR of 7.4% during the forecast period, the segment is going to dominate. Trauma centers are touted to grow with 7.2% CAGR during the review period.


    Regional Analysis:


    Geographically, the intracranial pressure monitoring market includes the Americas, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA).


    The Americas can expect the highest market growth during the forecast period. Its expected CAGR will hover around 7.3% CAGR during the forecast period, and the regional market can easily scale to a valuation of USD 844.8 million by 2024. Superior infrastructure and substantial healthcare investment are driving the market further ahead. At the same time, the region can boast of significant technological advancement.


    Europe assumes the second spot with a considerable market share of USD 445.7 million which could go up and create a market value of USD 676.7 million with a 7.2% CAGR during the forecast period. Healthcare setup of the region is quite similar to that of the Americas, and government investment and funding can take the market to new heights.


    The APAC, owing to an upheaval in the healthcare sector can now expect a steady rise to a valuation of USD 420.6 million during the forecast period. The rise would be better than the rest, and the anticipated CAGR would be of 7.4% during the forecast period.


    The MEA will have slow and steady growth. Lack of infrastructure is bogging the market down, and a meager 2.6% CAGR can be expected from this region.


    Market Landscape:


    The oligopolistic market of the intracranial pressure monitoring is experiencing several strategic implementations with leading companies getting involved in the tactical collaboration, mergers, acquisitions, and new product launches. For instance, Terumo Corporation has bought Sequent Medical, Inc, a company that develops new devices for aneurysm embolization. On the other hand, Natus Medical Incorporated has acquired the neurosurgery business wing from Integra LifeSciences which can be considered exemplary.


    Key companies operating in the intracranial pressure monitoring market are Integra LifeSciences Corporation, DePuy Synthes, Spiegelberg GmbH & Co.KG, RAUMEDIC Inc., Sophysa SA, Boston Neurosciences, Medtronic Plc., Terumo Corporation, Natus Medical Incorporated, and others.   

    1 Report Prologue

    2 Market Introduction

    2.1 Scope Of Study 17

    2.2 Research Objective 17

    2.3 List Of Assumptions 18

    2.4 Market Structure 18

    3 Research Methodology

    3.1 Research Process 20

    3.2 Primary Research 21

    3.3 Secondary Research 22

    3.4 Market Size Estimation 23

    3.5 Forecast Model 23

    4 Market Dynamics

    4.1 Introduction 25

    4.2 Drivers 25

    4.2.1 Increasing Prevalence Of Neurovascular Diseases, Such As Brain Aneurysm, Arteriovenous Malformations (AVMs), And Others, Are Likely To Propel The ICP Monitoring Market 25

    4.2.2 Favourable Reimbursement Policies Provide Favourable Background For The Market Growth 26

    4.2.3 Growing Prevalence Of Traumatic Brain Injuries 26

    4.2.4 Ongoing Product Development & Commercialization Will Boost The ICP Monitoring Market 26

    4.3 Restraints 27

    4.3.1 The Shortage Of Trained Professionals 27

    4.3.2 High Procedural Cost Of ICP Monitoring Devices 27

    4.4 Opportunities 27

    4.4.1 Increasing Use Of Endovascular Embolization For The Treatment Of Brain Aneurysm 27

    4.5 Macroeconomic Indicators 28

    5 Market Factor Analysis

    5.1 Value Chain Analysis 30

    5.1.1 R&D & Designing 30

    5.1.2 Manufacturing 30

    5.1.3 Distribution & Sales 31

    5.1.4 Post-Sales Review 31

    5.2 Porter’s Five Forces Model 31

    5.2.1 Bargaining Power Of Suppliers 32

    5.2.2 Bargaining Power Of Buyers 32

    5.2.3 Threat Of New Entrants 32

    5.2.4 Threat Of Substitutes 33

    5.2.5 Intensity Of Rivalry 33

    5.3 Re-Operation Rate Analysis 33

    5.4 Complication Rate Analysis 33

    6 Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    6.1 Introduction 35

    6.2 Intraventricular 36

    6.3 Epidural Sensor 36

    7 Intracranial Pressure (ICP) Monitoring Market, By Technique

    7.1 Introduction 38

    7.2 Invasive 39

    7.3 Non-Invasive 39

    7.3.1 Transcranial Doppler Ultrasonography 39

    7.3.2 Tympanic Membrane Displacement (TMD) Analyzer 39

    7.3.3 Optic Nerve Sheath Diameter Sonography 40

    7.3.4 Fundoscopy (Papilledema) 40

    7.3.5 MRI/CT 40

    8 Intracranial Pressure (ICP) Monitoring Market, By Application

    8.1 Introduction 42

    8.2 Traumatic Brain Injury 43

    8.3 Intracerebral Hemorrhage 43

    8.4 Subarachnoid Hemorrhage 43

    8.5 Meningitis 44

    9 Intracranial Pressure (ICP) Monitoring Market, By Device

    9.1 Introduction 46

    9.2 Intraventricular Catheter 47

    9.3 Subarachnoid Screw 47

    9.4 Non-Invasive ICP Monitors 47

    9.5 Epidural Sensors 48

    10 Intracranial Pressure (ICP) Monitoring Market, By End User

    10.1 Introduction 50

    10.2 Hospitals & Clinic 51

    10.3 Trauma Centers 51

    11 Global Intracranial Pressure (ICP) Monitoring Market, By Region

    11.1 Introduction 53

    11.2 Americas 54

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.2.1 North America 56

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.2.1.1 US 59

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.2.1.2 Canada 61

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.2.2 South America 63

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.3 Europe 65

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.3.1 Western Europe 68

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.3.1.1 Germany 70

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.3.1.2 France 72

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.3.1.3 UK 74

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.3.1.4 Italy 76

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.3.1.5 Spain 78

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.3.1.6 Rest Of Western Europe 80

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.3.2 Eastern Europe 83

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.4 Asia-Pacific 85

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.4.1 Japan 87

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.4.2 China 89

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.4.3 India 91

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.4.4 Australia 93

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.4.5 Rest Of Asia-Pacific 95

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.5 Middle East & Africa 98

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.5.1 Middle East 100

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.5.2 Africa 102

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    11.5.3 Rest Of Middle East & Africa 104

    Intracranial Pressure (ICP) Monitoring Market, By Route Of Intervention

    Intracranial Pressure (ICP) Monitoring Market, By Technique

    Intracranial Pressure (ICP) Monitoring Market, By Application

    Intracranial Pressure (ICP) Monitoring Market, By Device

    Intracranial Pressure (ICP) Monitoring Market, By End User

    12 Competitive Landscape

    12.1 Company Market Share Analysis 108

    12.1.1 Introduction 108

    12.2 Competitive Landscape 109

    12.2.1 Introduction 109

    12.3 Key Developments 110

    13 Company Profiles

    13.1 Integra LifeSciences Corporation 112

    13.1.1 Company Overview 112

    13.1.2 Financial Overview 112

    13.1.3 Products Offered 113

    13.1.4 Key Developments 113

    13.1.5 SWOT Analysis 113

    13.1.6 Key Strategies 113

    13.2 DePuy Synthes 114

    13.2.1 Company Overview 114

    13.2.2 Financial Overview 114

    13.2.3 Products Offered 115

    13.2.4 Key Developments 115

    13.2.5 SWOT Analysis 115

    13.2.6 Key Strategies 115

    13.3 Spiegelberg GmbH & Co. KG 116

    13.3.1 Company Overview 116

    13.3.2 Financial Overview 116

    13.3.3 Products Offered 116

    13.3.4 Key Developments 116

    13.3.5 SWOT Analysis 116

    13.3.6 Key Strategies 116

    13.4 RAUMEDIC Inc 117

    13.4.1 Company Overview 117

    13.4.2 Financial Overview 117

    13.4.3 Products Offered 117

    13.4.4 Key Developments 117

    13.4.5 SWOT Analysis 117

    13.4.6 Key Strategies 117

    13.5 Sophysa SA 118

    13.5.1 Company Overview 118

    13.5.2 Financial Overview 118

    13.5.3 Products Offered 118

    13.5.4 Key Developments 118

    13.5.5 SWOT Analysis 118

    13.5.6 Key Strategies 118

    13.6 Boston Neurosciences 119

    13.6.1 Company Overview 119

    13.6.2 Financial Overview 119

    13.6.3 Products Offered 119

    13.6.4 Key Developments 119

    13.6.5 SWOT Analysis 119

    13.6.6 Key Strategies 119

    13.7 Medtronic Plc 120

    13.7.1 Company Overview 120

    13.7.2 Financial Overview 120

    13.7.3 Products Offered 121

    13.7.4 Key Developments 121

    13.7.5 SWOT Analysis 121

    13.7.6 Key Strategies 121

    13.8 Terumo Corporation 122

    13.8.1 Company Overview 122

    13.8.2 Financial Overview 122

    13.8.3 Products Offered 123

    13.8.4 Key Developments 123

    13.8.5 SWOT Analysis 123

    13.8.6 Key Strategies 123

    13.9 Natus Medical Incorporated 124

    13.9.1 Company Overview 124

    13.9.2 Financial Overview 124

    13.9.3 Products Offered 125

    13.9.4 Key Developments 125

    13.9.5 SWOT Analysis 125

    13.9.6 Key Strategies 125

    14 Appendix

    14.1 Discussion Blue Print 127

    15 List Of Tables

    TABLE 1 LIST OF ASSUMPTIONS 18

    TABLE 2 PRIMARY INTERVIEWS 20

    TABLE 3 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 35

    TABLE 4 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INTRAVENTRICULAR 2020–2027 (USD MILLION) 36

    TABLE 5 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY EPIDURAL SENSOR 2020–2027 (USD MILLION) 36

    TABLE 6 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 38

    TABLE 7 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 39

    TABLE 8 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE 2020–2027 (USD MILLION) 39

    TABLE 9 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 42

    TABLE 10 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TRAUMATIC BRAIN INJURY 2020–2027 (USD MILLION) 43

    TABLE 11 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INTRACEREBRAL HEMORRHAGE 2020–2027 (USD MILLION) 43

    TABLE 12 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY SUBARACHNOID HEMORRHAGE 2020–2027 (USD MILLION) 43

    TABLE 13 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY MENINGITIS 2020–2027 (USD MILLION) 44

    TABLE 14 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICE 2020–2027 (USD MILLION) 46

    TABLE 15 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INTRAVENTRICULAR CATHETER 2020–2027 (USD MILLION) 47

    TABLE 16 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY SUBARACHNOID SCREW 2020–2027 (USD MILLION) 47

    TABLE 17 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY NON-INVASIVE ICP MONITORS 2020–2027 (USD MILLION) 47

    TABLE 18 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY EPIDURAL SENSORS 2020–2027 (USD MILLION) 48

    TABLE 19 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USER 2020–2027 (USD MILLION) 50

    TABLE 20 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY HOSPITALS & CLINIC 2020–2027 (USD MILLION) 51

    TABLE 21 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TRAUMA CENTERS 2020–2027 (USD MILLION) 51

    TABLE 22 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY REGION 2020–2027 (USD MILLION) 53

    TABLE 23 AMERICASINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY REGION 2020–2027 (USD MILLION) 54

    TABLE 24 AMERICASINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 54

    TABLE 25 AMERICASINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 55

    TABLE 26 AMERICASINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 55

    TABLE 27 AMERICASINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 55

    TABLE 28 AMERICASINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 56

    TABLE 29 AMERICASINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 56

    TABLE 30 NORTH AMERICAINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY COUNTRY 2020–2027 (USD MILLION) 56

    TABLE 31 NORTH AMERICAINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 57

    TABLE 32 NORTH AMERICAINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 57

    TABLE 33 NORTH AMERICAINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 58

    TABLE 34 NORTH AMERICAINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 58

    TABLE 35 NORTH AMERICAINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 58

    TABLE 36 NORTH AMERICAINTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 59

    TABLE 37 US INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 59

    TABLE 38 US INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 59

    TABLE 39 US INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 59

    TABLE 40 US INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 60

    TABLE 41 US INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 60

    TABLE 42 US INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 60

    TABLE 43 CANADA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 61

    TABLE 44 CANADA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 61

    TABLE 45 CANADA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 61

    TABLE 46 CANADA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 62

    TABLE 47 CANADA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 62

    TABLE 48 CANADA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 62

    TABLE 49 SOUTH AMERICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 63

    TABLE 50 SOUTH AMERICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 63

    TABLE 51 SOUTH AMERICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 63

    TABLE 52 SOUTH AMERICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 64

    TABLE 53 SOUTH AMERICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 64

    TABLE 54 SOUTH AMERICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 64

    TABLE 55 EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY REGION 2020–2027 (USD MILLION) 65

    TABLE 56 EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 65

    TABLE 57 EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 66

    TABLE 58 EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 66

    TABLE 59 EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 66

    TABLE 60 EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 67

    TABLE 61 EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 67

    TABLE 62 WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY COUNTRY 2020–2027 (USD MILLION) 68

    TABLE 63 WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 68

    TABLE 64 WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 69

    TABLE 65 WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 69

    TABLE 66 WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 69

    TABLE 67 WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 70

    TABLE 68 WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 70

    TABLE 69 GERMANY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 70

    TABLE 70 GERMANY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 71

    TABLE 71 GERMANY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 71

    TABLE 72 GERMANY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 71

    TABLE 73 GERMANY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 72

    TABLE 74 GERMANY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 72

    TABLE 75 FRANCE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 72

    TABLE 76 FRANCE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 73

    TABLE 77 FRANCE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 73

    TABLE 78 FRANCE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 73

    TABLE 79 FRANCE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 74

    TABLE 80 FRANCE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 74

    TABLE 81 UK INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 74

    TABLE 82 UK INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 75

    TABLE 83 UK INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 75

    TABLE 84 UK INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 75

    TABLE 85 UK INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 76

    TABLE 86 UK INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 76

    TABLE 87 ITALY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 76

    TABLE 88 ITALY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 77

    TABLE 89 ITALY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 77

    TABLE 90 ITALY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 77

    TABLE 91 ITALY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 78

    TABLE 92 ITALY INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 78

    TABLE 93 SPAIN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 78

    TABLE 94 SPAIN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 79

    TABLE 95 SPAIN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 79

    TABLE 96 SPAIN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 79

    TABLE 97 SPAIN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 80

    TABLE 98 SPAIN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 80

    TABLE 99 REST OF WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 80

    TABLE 100 REST OF WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 81

    TABLE 101 REST OF WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 81

    TABLE 102 REST OF WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 81

    TABLE 103 REST OF WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 82

    TABLE 104 REST OF WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 82

    TABLE 105 EASTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 83

    TABLE 106 EASTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 83

    TABLE 107 EASTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 83

    TABLE 108 EASTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 84

    TABLE 109 EASTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 84

    TABLE 110 EASTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 84

    TABLE 111 ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY REGION 2020–2027 (USD MILLION) 85

    TABLE 112 ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 85

    TABLE 113 ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 86

    TABLE 114 ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 86

    TABLE 115 ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 86

    TABLE 116 ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 87

    TABLE 117 ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 87

    TABLE 118 JAPAN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 87

    TABLE 119 JAPAN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 88

    TABLE 120 JAPAN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 88

    TABLE 121 JAPAN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 88

    TABLE 122 JAPAN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 89

    TABLE 123 JAPAN INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 89

    TABLE 124 CHINA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 89

    TABLE 125 CHINA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 90

    TABLE 126 CHINA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 90

    TABLE 127 CHINA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 90

    TABLE 128 CHINA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 91

    TABLE 129 CHINA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 91

    TABLE 130 INDIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 91

    TABLE 131 INDIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 92

    TABLE 132 INDIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 92

    TABLE 133 INDIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 92

    TABLE 134 INDIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 93

    TABLE 135 INDIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 93

    TABLE 136 AUSTRALIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 93

    TABLE 137 AUSTRALIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 94

    TABLE 138 AUSTRALIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 94

    TABLE 139 AUSTRALIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 94

    TABLE 140 AUSTRALIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 95

    TABLE 141 AUSTRALIA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 95

    TABLE 142 REST OF ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 95

    TABLE 143 REST OF ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 96

    TABLE 144 REST OF ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 96

    TABLE 145 REST OF ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 96

    TABLE 146 REST OF ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 97

    TABLE 147 REST OF ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 97

    TABLE 148 MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY REGION 2020–2027 (USD MILLION) 98

    TABLE 149 MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 98

    TABLE 150 MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 99

    TABLE 151 MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 99

    TABLE 152 MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 99

    TABLE 153 MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 100

    TABLE 154 MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 100

    TABLE 155 MIDDLE EAST INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 100

    TABLE 156 MIDDLE EAST INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 101

    TABLE 157 MIDDLE EAST INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 101

    TABLE 158 MIDDLE EAST INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 101

    TABLE 159 MIDDLE EAST INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 102

    TABLE 160 MIDDLE EAST INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 102

    TABLE 161 AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 102

    TABLE 162 AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 103

    TABLE 163 AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 103

    TABLE 164 AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 103

    TABLE 165 AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 104

    TABLE 166 AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 104

    TABLE 167 REST OF MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020–2027 (USD MILLION) 104

    TABLE 168 REST OF MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020–2027 (USD MILLION) 105

    TABLE 169 REST OF MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY INVASIVE TECHNIQUE 2020–2027 (USD MILLION) 105

    TABLE 170 REST OF MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020–2027 (USD MILLION) 105

    TABLE 171 REST OF MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICES 2020–2027 (USD MILLION) 106

    TABLE 172 REST OF MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USERS 2020–2027 (USD MILLION) 106

    TABLE 173 GLOBAL ICP MONITORINGS MARKET: KEY DEVELOPMENT 110

    16 List Of Figures

    FIGURE 1 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET: MARKET STRUCTURE 18

    FIGURE 2 RESEARCH PROCESS 20

    FIGURE 3 TOP-DOWN AND BOTTOM-UP APPROACH 23

    FIGURE 4 VALUE CHAIN: GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET 30

    FIGURE 5 PORTER’S FIVE FORCES MODEL: GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET 32

    FIGURE 6 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY ROUTE OF INTERVENTION 2020&2027 35

    FIGURE 7 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE 2020&2027 38

    FIGURE 8 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION 2020&2027 42

    FIGURE 9 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY DEVICE 2020&2027 46

    FIGURE 10 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USER 2020&2027 50

    FIGURE 11 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET SHARE: BY REGION 2020 (%) 53

    FIGURE 12 AMERICASINTRACRANIAL PRESSURE (ICP) MONITORING MARKET SHARE: BY REGION 2020 (%) 54

    FIGURE 13 NORTH AMERICAINTRACRANIAL PRESSURE (ICP) MONITORING MARKET SHARE: BY REGION 2020 (%) 57

    FIGURE 14 EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET SHARE: BY REGION 2020 (%) 65

    FIGURE 15 WESTERN EUROPE INTRACRANIAL PRESSURE (ICP) MONITORING MARKET SHARE: BY REGION 2020 (%) 68

    FIGURE 16 ASIA-PACIFIC INTRACRANIAL PRESSURE (ICP) MONITORING MARKET SHARE: BY REGION 2020 (%) 85

    FIGURE 17 MIDDLE EAST & AFRICA INTRACRANIAL PRESSURE (ICP) MONITORING MARKET SHARE: BY REGION 2020 (%) 98

    FIGURE 18 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, MARKET SHARE ANALYSIS 2020 (%) 108

    FIGURE 19 GLOBAL INTRACRANIAL PRESSURE (ICP) MONITORING MARKET COMPETITIVE LANDSCAPE (%) 109

    Global Intracranial Pressure Monitoring (ICP) Monitoring Market: Competitive Landscape


    The prominent players in the global intracranial pressure monitoring market are Integra LifeSciences, Codman & Shurtleff, Medtronic Plc, RAUMEDIC, Spiegelberg, Vittamed, and DePuy Synthes


    Integra LifeSciences Corporation is the holds the largest share for the global intracranial pressure monitoring market in 2017. The company is an international leader in medical technology. The key focus of the company is to provide patients with a high level of satisfaction. The company also provides and operates innovative solutions in the field of orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. In the US, Integra LifeSciences Corporation is one of the leading players for providing surgical devices and instruments to various hospitals, surgery centers, physicians, and dental offices.


    Natus Medical Incorporated supplies newborn care, neurology, and hearing and balance assessment healthcare products. It provides products and services used for the diagnosis, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. For instance, in Septmeber-2017, Natus Medical Incorporated acquired neurosurgery business assets from Integra LifeSciences, thus entering into the neurosurgery business segment.


    Terumo Corporation manufactures and distributes medical devices and services worldwide. The company offers vascular intervention devices, such as introducer sheaths, guide wires, angiographic catheters, and radial artery compression devices; therapeutic devices; and intravascular imaging systems. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in 1974. For instance, in July 2016, Terumo Corporation entered into an agreement to purchase Sequent Medical, Inc., a privately-held firm developing a new medical device for aneurysm embolization, thus, expanding the portfolio of neurovascular products.


    Medtronic Plc is a global healthcare solutions company committed to improving the lives of people through medical technologies, services, and solutions. Medtronics Plc with Covidien has accelerated and advanced its ability to create meaningful innovations for hospitals, health systems, and healthcare providers so that it can deliver the best care possible to patients and their families around the world. For instance, in April 2018, Medtronic plc announced two-year outcomes for the Harmony (TM) Transcatheter Pulmonary Valve (TPV) from its early feasibility study. The study was presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 41st Annual Scientific Sessions.


    Codman & Shurtleff and Integra LifeSciences are the major companies for ICP monitoring operating on a global scale. The lower market share of Johnson & Johnson Services Inc. can be attributed to fewer products offering, as compared to Sanofi S.A and other major players. Major players such as Medtronic Plc, RAUMEDIC, Spiegelberg, Vittamed, and DePuy Synthes, increase the level of competition in the global ICP monitoring market, as these companies are expected to expand their product portfolios, with the help of other business units, to increase their market share.


    Four major players, namely, Integra LifeSciences, Codman & Shurtleff, Natus Medical Incorporated, and Medtronic Plc. account for more than three fourth share of the global Intracranial Pressure (ICP) monitoring market.